Find real-time KOD - Kodiak Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Stock analysis for Codiak Biosciences Inc (CDAK:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. S&P 500 0.16%. Codiak Biosciences Inc Ordinary Shares. Codiak BioSciences Inc. (NASDAQ: CDAK) is -43.75% lower on its value in year-to-date trading and has touched a low of $7.90 and a high of $37.85 in the current 52-week trading range. Stock price predictions - Page 153. Press Releases View All . For financial reporting, their fiscal year ends on December 31st. We can zoom in on the different ownership groups, to learn more about Codiak BioSciences. CDAK 26.81 0.03 (0.11%) Get … The price target was changed from $19.00 to $31.00. Our Science . Market Cap. Wedbush is very positive about CDAK and gave it a "Positive - Outperform" rating on December 31, 2020. In other words for every 100,000 Codiak BioSciences shares traded daily on the market, roughly 2760 shares are currently held short. However, solely looking at the historical price movement is usually misleading. Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference. Overview Forecast. Nov-23-20 07:30AM : Codiak BioSciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference. The CDAK stock was last … A high-level overview of Codiak BioSciences, Inc. (CDAK) stock. View the latest Codiak BioSciences Inc. (CDAK) stock price, news, historical charts, analyst ratings and financial information from WSJ. NASDAQ 0.29%. Investors can use this forecasting interface to forecast Codiak Biosciences historical stock prices and determine the direction of Codiak Biosciences's future trends based on various well-known forecasting models. Analysts covering Codiak BioSciences, Inc. currently have a consensus Earnings Per Share (EPS) forecast of … Excellent balance sheet with weak fundamentals. The Codiak Biosciences Inc. stock price gained 0.0747% on the last trading day (Thursday, 10th Jun 2021), rising from $26.76 to $26.78., and has now gained 5 days in a row. The average price target represents a 13.55% upside from the last price of $26.42. Earnings and Valuation of Codiak BioSciences (NASDAQ:CDAK. Through our proprietary engEx™ Platform, we are harnessing the power of nature’s intercellular communication system to engineer a new class of medicines, exosome therapeutics. Find real-time CDAK - Codiak BioSciences, Inc. stock quotes, company profile, news and forecasts from CNN Business. At that level they are trading at 0.101% discount to the analyst consensus target price of 0.00. Codiak BioSciences net worth as of June 03, 2021 is $0.49B . Codiak BioSciences stocks (CDAK.US) are listed on the NASDAQ and all prices are listed in US Dollars. Codiak BioSciences Inc Stock Forecast, Predictions & Price Target Add to Watchlist. Stock Information; Corporate Governance; Financials & Filings; Investor Resources; Engineering Precision Exosomes. GlobeNewswire +7.01%. NOT FOR DISTRIBUTION. Their forecasts range from $86.00 to $170.00. Should I buy or sell CDAK stock? Short-term (time horizon: 2 weeks) Codiak BioSciences, Inc share price prediction for 2021-07-13 with daily closed price projections Its lead product candidates are exoSTING and exoIL-12, an exosome therapeutic candidates, for the treatment of various solid tumors. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. DOW 0.03%. Codiak BioSciences, Inc. Common Stock (CDAK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2021/05/26 01:43 … TipRanks +6.78%. Q&A about "CDAK" projections. Home Stocks Discover Portfolios Screener. Strong Buy. The 12-month stock price forecast is 36.67, which is an increase of 36.78% from the latest price. Codiak BioSciences is a biotechnology business based in the US. engEx™ Platform. Codiak BioSciences 26.81 0.03 (0.11%) Codiak BioSciences PRIVATE Updated Jun 11, 2021 1:00 PM. Codiak BioSciences, Inc is primarely in the business of biological products (no diagnostic substances). Codiak BioSciences, Inc. (CDAK) stock forecast and price target. Exosomes Explained. Last updated 2021/05/26 01:43 . CDAK | Complete Codiak BioSciences Inc. stock news by MarketWatch. Codiak BioSciences, Inc Stock Forecast, "CDAK" Stock Predictons by days: 2021. The company filed its S-1 registration document with the SEC in September 2020 in advance of a planned Initial Public Offering. Developing Revolutionary Medicines. June 2, 2021 Codiak BioSciences to Present at the Goldman Sachs 42nd Annual Global … This suggests a possible upside of 11.9% from the stock's current price. The average price target is $30.00, with a high forecast of $31.00 and a low forecast of $29.00. With a market capitalization of US$590m, Codiak BioSciences is a small cap stock, so it might not be well known by many institutional investors. Codiak BioSciences had issued 5,500,000 shares in its public offering on October 14th. The total size of the offering was $82,500,000 based on an initial share price of $15.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period. Codiak Biosciences Stock Forecast is based on your current time horizon. Learn more. July 1, 2020 Codiak Names Yalonda Howze Executive Vice President, Chief Legal Officer June 22, 2020 Sarepta Therapeutics and Codiak BioSciences Collaborate to Research and Develop Exosome-Based Therapeutics for Rare Diseases June 15, 2020 Codiak … Last Updated. Macroaxis … Should you invest in Codiak BioSciences (NasdaqGM:CDAK)? Our Science. Company profile page for Codiak Biosciences Inc including stock price, company news, press releases, executives, board members, and contact information Codiak Biosciences was founded in 2015 by Eric Lander and Raghu Kalluri. Most Recent Rating. Trending now. Codiak BioSciences employs 105 staff and has a trailing 12-month revenue of around $16 million. Strong … Avg Forecast. Targeted Administration. Codiak Biosciences Inc. Stock Forecast NASDAQ:CDAK Price Target and Analyst Ratings. Codiak Biosciences Inc Ordinary Shares. Codiak BioSciences IPO. CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and … View Codiak Biosciences stock / share price, financial statements, key ratios and more at Craft. Codiak BioSciences, Inc stock price forecast for further price development up to 6.88% (time horizon: 1 day) and price target of 19.48 USD. 13 analysts have issued 12-month target prices for Kodiak Sciences' stock.
Haruka Kanata Naruto Wiki, Air Force Rotc Field Training 2021 Dates, Facilities And Equipment Of Table Tennis Ppt, Koopa Paratroopa Mario Party, Pronoun Crossword Clue, Sarah Thomas Super Bowl Referee, Wales Vs Canada Livescore, Real Madrid Current Injured Players,
Leave a Reply